RXRX Market Cap & Key Metrics
Recursion Pharmaceuticals, Inc.
$3.86
+$0.12(+3.21%)
59
Overall
60
Value
75
Tech
44
Quality
Market Cap
$2.00B
Volume
14.79M
52W Range
$2.77 - $7.18
Target Price
$6.90
RXRX market cap is $2.00B. This page lists Recursion Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RXRX Key Metrics
- Market cap
- $2.00B
- EPS estimate, current year
- $-0.94
- EPS growth, 3-year
- -1.92%
- Value score
- 60
- Quality score
- 44
- Technical score
- 75
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $74.68M | $58.84M | $44.58M | $39.84M | $10.18M |
| EBITDA | -$561.19M | -$428.29M | -$307.73M | -$288.89M | -$175.12M |
| EPS | $-1.44 | $-1.69 | $-1.58 | $-1.36 | $-1.49 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RXRX | $3.86 | +3.2% | 14.79M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Recursion Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW